• Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer
Sunday, January 29, 2023
SLC Metro News
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Popular
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Popular
No Result
View All Result
No Result
View All Result
Home Technology Gaming

U.S. To Share Some Coronavirus Technologies With World Health Organization – The Washington Post

us.-to-share-some-coronavirus-technologies-with-world-health-organization-–-the-washington-post
Share on FacebookShare on Twitter

The Biden administration will share U.S. government-devised coronavirus technologies with the World Health Organization, a policy shift intended to allow other countries to replicate some American scientific breakthroughs and better fight the pandemic abroad, federal officials said Thursday.

Under the plan, some technologies now being developed by the National Institutes of Health will be licensed to the WHO’s COVID-19 Technology Access Pool, senior NIH official Anthony S. Fauci told reporters. The technologies will also be sub-licensed to the United Nations-backed Medicines Patent Pool.

Fauci declined to detail which technologies would be made available for licensing by other countries, saying the plan’s details were “still being ironed out.” The new policy is not intended to apply to the vaccines and therapeutics that have been developed by private companies and are currently in the U.S. market, according to three people familiar with the plan who spoke on the condition of anonymity because they were not authorized to speak with the news media.

Story continues below advertisement

The United States is not expected to share NIH-developed technology that was used by Moderna, the vaccine maker that worked closely with the U.S. government in its messenger RNA vaccine. Foreign countries and developers have long petitioned for access to Moderna’s technology and know-how, saying that it would allow them to more quickly replicate their own versions of Moderna’s vaccine.

Sharing the technologies behind NIH-devised coronavirus diagnostics, treatments and vaccines is intended to allow other nations and developers to replicate the manufacturing process. As a result, officials expect the decision to more quickly build a global stockpile of supplies to combat the pandemic.

“I thank NIH for its offer of innovative therapeutics, vaccines and diagnostic methods for COVID-19,” WHO Director General Tedros Adhanom Ghebreyesus said in a statement. “Voluntary sharing of technologies through non-exclusive agreements will not only help us put the pandemic behind us; it will also empower low- and middle-income countries to produce their own medical products and achieve equitable access.”

Story continues below advertisement

The WHO, dozens of foreign countries and public health advocates have spent nearly two years urging the United States and other wealthy nations to share the technologies linked with their coronavirus vaccines, diagnostics and therapeutics.

Spain in November announced that it would share the technology behind a coronavirus antibody test with the WHO, the first significant donation to the pool, known as C-TAP.

U.S. participation in the WHO pool could jump-start global donations of such technologies, officials and advocates said.

“The U.S. government sets the tone for country relationships toward the pharmaceutical industry, as well as this sort of global cooperation,” said Peter Maybarduk, who oversees the global medicine program at Public Citizen, an advocacy organization. “And by taking the publicly owned inventions and working with WHO to make them available to humanity … that is a clear and powerful demonstration of what governments can do.”

SLC Metro News

© 2021 SLC Metro News

Navigate Site

  • Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer

Follow Us

No Result
View All Result
  • Home
  • DMCA Policy
  • Medical Disclaimer
  • Privacy Policy
  • Disclosure
  • CCPA
  • Terms of Use

© 2021 SLC Metro News

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT